NOTCH1 and adrenal cortex carcinoma: We then integrated our new ACC gene signature with data from three recent whole exome ACC sequencing studies [30-32] and identified RUNX1 and NOTCH1 as the only overlapping genes targeted for potential gain of function mutations (missense or C-terminal truncated protein) and associated with elevated gene expression (Figure 3D).